Retinal Vein Occlusion

This happens when a vein that carries blood out of the retina gets blocked. This can cause fluid buildup and swelling in the retina, leading to vision loss.

Condition

What people with Retinal Vein Occlusion report

Every report comes from a Lived member, sent anonymously.

Have you tried Eylea (Aflibercept) for Retinal Vein Occlusion?

NameHow it went

About Retinal Vein Occlusion

What It Is

Retinal vein occlusion (RVO) is a blockage in one of the veins that carry blood away from the retina, the light-sensing layer at the back of the eye. When blood cannot drain normally, it backs up, and blood and fluid leak into the retina. The most common result is swelling of the macula, the small central area of the retina responsible for sharp detail, which blurs the vision you use for reading, faces and driving. There are two main types. Branch retinal vein occlusion (BRVO) blocks one of the smaller branch veins and is the more common form; it usually affects only part of the field of vision in one eye. Central retinal vein occlusion (CRVO) blocks the main vein where it leaves the eye and can affect part or all of that eye's vision. The typical symptom is painless blurring or loss of vision in one eye, either suddenly or worsening over several hours or days. Some people notice new floaters, dark spots or threads caused by small amounts of blood inside the eye. Others have no symptoms at first, and the occlusion is found during a routine eye exam.

Causes & Risk Factors

RVO most often develops when a stiffened retinal artery presses on a vein where the two cross, slowing blood flow and making a clot more likely to form. That is why it is closely tied to conditions that damage blood vessels. Most people affected are over 50, and the main risk factors are high blood pressure, diabetes, high cholesterol and hardening of the arteries. Glaucoma or raised pressure inside the eye also increases the risk, and smoking adds to it. These factors raise the odds rather than explain every case; sometimes no clear cause is found. When RVO occurs in someone under about 40, or in both eyes, doctors may look for less common causes such as a blood clotting disorder or inflammation of the blood vessels.

How It's Diagnosed

An ophthalmologist (eye doctor) diagnoses RVO by widening the pupils with drops and examining the retina, where a blocked vein leaves a characteristic pattern of bleeding and swelling. Optical coherence tomography (OCT), a quick, painless scan, measures how thick and swollen the retina is. Those measurements matter beyond diagnosis: repeat OCT scans are how the doctor decides whether treatment is working and when the next one is needed. Fluorescein angiography, in which a dye is injected into an arm vein and photographed as it passes through the eye, shows how much of the retina has lost its blood supply. OCT angiography can give similar information without dye. This helps separate milder occlusions from ischemic ones, where large areas of retina are starved of blood and the risk of complications is higher. Because RVO reflects the health of blood vessels throughout the body, the assessment usually includes checking blood pressure, blood sugar and cholesterol, often together with a primary care clinician.

Treatment Options

There is no safe way to reopen the blocked vein itself. Treatment instead aims to protect and, when possible, improve vision by controlling the swelling and preventing complications, while the underlying blood vessel risk factors are treated at the same time. For swelling of the macula, the usual first choice is a series of injections into the eye of medicines that block vascular endothelial growth factor (VEGF), a protein the starved retina releases that makes vessels leak and drives the growth of fragile new ones. Blocking it reduces swelling. Options include aflibercept (Eylea), ranibizumab (Lucentis), faricimab (Vabysmo) and bevacizumab (Avastin, a cancer medicine widely used in the eye off-label), and studies show broadly similar vision results among them. The eye is numbed first, and the injection takes only moments. The main trade-off is commitment: the effect wears off and the swelling can return, so injections are often given monthly at first and then spaced out as the eye allows, sometimes for a year or two or longer. Steroid medicine given into the eye, such as the slow-release dexamethasone implant (Ozurdex), also reduces swelling and may need fewer visits. It commonly raises eye pressure and speeds cataract formation, so it is often used when anti-VEGF treatment is not enough or is less suitable. Laser treatment has two different roles: a focal laser around the macula can reduce leakage in some branch occlusions, and a broader laser across the oxygen-starved retina is used when abnormal new blood vessels start to grow, to lower the risk of bleeding and dangerous pressure rises. Surgery to remove blood from inside the eye (vitrectomy) is reserved for bleeding that does not clear or for retinal detachment.

What to Expect

Outlook depends mostly on the type of occlusion and how much of the retina has lost its blood supply. Many people with a branch occlusion keep or regain useful vision, and some improve even without treatment. Central occlusions vary more: milder ones can recover well, while ischemic ones often leave lasting vision loss. With treatment, improvement usually builds over a few months. Most people gain some vision, but not everyone does, and keeping the macula dry can still prevent further loss. The practical burden is regular appointments for scans and injections, often over a long period. Vision may be blurry after a visit, so many people need someone to drive them. Follow-up also watches for abnormal new blood vessels, which in ischemic central occlusions most often appear within the first few months and can cause bleeding or a painful form of glaucoma if not treated early. RVO is also a signal about general health. People who have had one face a higher risk of heart disease and stroke, largely because of the same underlying risk factors, and a somewhat higher chance of a vein occlusion in the other eye. Controlling blood pressure, diabetes and cholesterol and not smoking protect both the eyes and the rest of the body. If vision stays limited, low vision rehabilitation can teach techniques and provide magnifiers and other tools for reading and daily tasks.

When to Seek Help

Sudden blurring, a dark area or loss of vision in one eye, a burst of new floaters, flashes of light, or a shadow spreading across your vision need medical care right away rather than a routine appointment, because RVO and other serious retinal problems are treated best early. If you are being treated, contact your eye doctor immediately if, in the days after an injection, the eye becomes red, painful or sensitive to light or your vision gets worse, as these can be signs of infection or retinal detachment. Also call promptly about new eye pain, pressure or redness, which can signal a dangerous rise in eye pressure. Keep scheduled visits even when your vision feels stable, and see your primary care clinician to review blood pressure, blood sugar and cholesterol.

Questions to Ask Your Doctor

  1. 1.Is this a branch or central occlusion, and how much of my retina has lost its blood supply?
  2. 2.Which treatment do you recommend for me, and how will we decide when to space out or stop treatment?
  3. 3.How much vision can I realistically expect to recover, and over what time frame?
  4. 4.What should we check about my blood pressure, blood sugar, cholesterol or clotting to lower my risk of another occlusion or a stroke?
  5. 5.What will follow-up involve, and can I drive myself to and from treatment visits?

Last reviewed • Oct 2026

Educational content, not medical advice.